Akums Receives DCGI Approval for Colchicine 0.5 mg Tablets, Expanding Preventive Cardiology Portfolio

New Delhi: Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organization (CDMO), has received DCGI approval for Colchicine 0.5 mg Tablets, marking a significant addition to its cardiovascular and preventive cardiology portfolio. The approval represents a first-time-in-India regulatory milestone for this application and reinforces Akums’ focus on differentiated therapies addressing evolving healthcare […] The post Akums Receives DCGI Approval for Colchici